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Development of new approaches for diagnosis and therapy of tumours (taken together, termed thera-
nostics) - one of the most dynamic areas of the life sciences, where new nanomaterials afford new opportuni-
ties. In virtue of their unique optical properties, fluorescent nanodiamonds1, nanorubies and upconversion na-
noparticles (UCNP)2 proved useful and even indispensable in cell and live animal imaging, as it will be demon-
strated in this talk. We developed facile modular strategies of surface functionalisation and coupling with func-
tional biomolecules, such as solid surface peptide binding3, 
which enabled targeted delivery of these nanoparticles and 
made theranostics applications conceivable. Attachment of 
therapeutic vectors Killer Red, Rose Bengal3 to UCNP 
proved effective for photodynamic therapy (PDT), as well 
as UCNP photosensitisation of FDA-approved Riboflavin 
(Vitamin B2)4, and even endogenous chromophors5, were 
demonstrated effective for PDT. A combination of agents, a 
bacterial exotoxin PE40 genetically fused with targeting 
protein DARPin and radioactive beta-emitter 90Y was dem-
onstrated to exhibit a profound super-additive therapeutic 
effect in excess of 2×103 in cells and live animal models6. A 
surprisingly large biodegradable inorganic drug delivery 
vehicles based on vaterite (CaCO3) sub-micrometre par-
ticles was demonstrated to deliver and release a high-
payload of drugs to the tumour sites enabling ablation of 
cancer cells. Nanotoxicology aspects of the developed bio-
hybrid nanocomplexes will be discussed and their applica-
tion prospects outlined. 
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A graphical representation of UCNP(
90
Y)- PE40-
DARPin biohybrid multifunctional complexes bind-
ing specifically to SK-BR-3 breast cancer cells. These 
enable optical labelling and combined therapy 
demonstrated in cells (front plane) and animals 
(background plane). Reproduced from Ref 6.   
